The Duration and Safety of Osteoporosis Treatment: Anabolic and Antiresorptive Therapy

Nursing and Health Professions

• Physician 100%
• Pathophysiology 100%
• Patient Care 50%
• Adverse Event 50%
• Treatment Failure 50%
• Clinical Decision Making 50%
• Femur Fracture 50%
• Jaw Osteonecrosis 50%
• Anabolic Agent 50%
• Angiographic Catheter 50%
• Drug Holiday 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Pathophysiology 100%
• Adverse Event 50%
• Drug 50%
• Anabolic Steroid 50%
• Femur Fracture 50%
• Jaw Osteonecrosis 50%
• Drug Holiday 50%

Medicine and Dentistry

• Osteoporosis 100%
• Clinician 33%
• Pathophysiology 33%
• Cohort Effect 16%
• Adverse Event 16%
• Patient Care 16%
• Clinical Decision Making 16%
• Decision Making 16%
• Drug 16%
• Anabolic Agent 16%
• Osteonecrosis of the Jaw 16%
• Femur Fracture 16%
• Drug Holiday 16%